North America extended its dominance for industrial automation hiring among clinical trial operations industry companies in the three months ending April.
The number of roles in North America made up 65.4% of total industrial automation jobs – up from 62.1% in the same quarter last year.
That was followed by Asia-Pacific, which saw a -0.9 year-on-year percentage point change in industrial automation roles.
The figures are compiled by GlobalData, who track the number of new job postings from key companies in various sectors over time. Using textual analysis, these job advertisements are then classified thematically.
GlobalData's thematic approach to sector activity seeks to group key company information by topic to see which companies are best placed to weather the disruptions coming to their industries.
These key themes, which include industrial automation, are chosen to cover "any issue that keeps a CEO awake at night".
By tracking them across job advertisements it allows us to see which companies are leading the way on specific issues and which are dragging their heels - and importantly where the market is expanding and contracting.
Which countries are seeing the most growth for industrial automation job ads in the clinical trial operations industry?
The fastest growing country was the United States, which saw 60.5% of all industrial automation job adverts in the three months ending April 2021, increasing to 62.5% in the three months ending April this year.
That was followed by Canada (up 1.3 percentage points), Singapore (0.7), and Ireland (-0.1).
The top country for industrial automation roles in the clinical trial operations industry is the United States which saw 62.5% of all roles advertised in the three months ending April.
Which cities are the biggest hubs for industrial automation workers in the clinical trial operations industry?
Some 2.3% of all clinical trial operations industry industrial automation roles were advertised in Cambridge (United States) in the three months ending April.
That was followed by Singapore (Singapore) with 2.2%, Rochester (United States) with 2.1%, and Boston (United States) with 2%.